Obesity and diabetes associated with dysregulation of mevalonate pathway markers and progression from pancreatic intraepithelial neoplasia to invasive pancreatic tumor.
- DOI
- 10.1186/s13287-026-05158-3
- Published
- 2026 Jul 11
- Container
- Stem cell research & therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s13287-026-05158-3,
title = {Obesity and diabetes associated with dysregulation of mevalonate pathway markers and progression from pancreatic intraepithelial neoplasia to invasive pancreatic tumor.},
author = {Rezagholizadeh F and Rokn S and FakherBaheri M and Taherian Z and Rostami H and Azmoudeh-Ardalan F and Rahimi M and Wadji MB and Kashanizadeh A and Eghtedari S and Lotfalizadeh A and Sharifi-Zarchi A and Safari E and Joghataei MT},
year = {2026},
journal = {Stem cell research \& therapy},
doi = {10.1186/s13287-026-05158-3},
url = {https://doi.org/10.1186/s13287-026-05158-3}
}RIS
TY - JOUR TI - Obesity and diabetes associated with dysregulation of mevalonate pathway markers and progression from pancreatic intraepithelial neoplasia to invasive pancreatic tumor. AU - Rezagholizadeh F AU - Rokn S AU - FakherBaheri M AU - Taherian Z AU - Rostami H AU - Azmoudeh-Ardalan F AU - Rahimi M AU - Wadji MB AU - Kashanizadeh A AU - Eghtedari S AU - Lotfalizadeh A AU - Sharifi-Zarchi A AU - Safari E AU - Joghataei MT PY - 2026 JO - Stem cell research & therapy DO - 10.1186/s13287-026-05158-3 UR - https://doi.org/10.1186/s13287-026-05158-3 ER -
APA
F, R., S, R., M, F., Z, T., H, R., F, A., M, R., MB, W., A, K., S, E., A, L., A, S., E, S., & MT, J. (2026). Obesity and diabetes associated with dysregulation of mevalonate pathway markers and progression from pancreatic intraepithelial neoplasia to invasive pancreatic tumor.. Stem cell research & therapy. https://doi.org/10.1186/s13287-026-05158-3
Source records
- pubmed · retrieved 2026-11-10T14:51:58.979Z